All Stories

  1. B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes

    Article • Diabetes, November 2025, American Diabetes Association

    Daniel Moore

  2. Use of Teplizumab to Modulate Stage 2 Type 1 Diabetes in Two Individuals With Autoimmune Polyendocrine Syndrome 1

    Article • Diabetes Care, November 2025, American Diabetes Association

    Daniel Moore

  3. A human IgM enriched immunoglobulin preparation, Pentaglobin, reverses autoimmune diabetes without immune suppression in NOD mice

    Article • Scientific Reports, July 2022, Springer Science + Business Media

    Daniel Moore

  4. Vascular alterations impede fragile tolerance to pregnancy in type 1 diabetes

    Article • F&S Science, May 2022, Elsevier

    Daniel Moore

  5. Diabetes Triples COVID-19 Severity: A Prospective Analysis

    Article • Diabetes Care, March 2022, American Diabetes Association

    Daniel Moore

  6. Physician-Scientist Training and Programming in Pediatric Residency Programs: A National Survey

    Article • The Journal of Pediatrics, February 2022, Elsevier

    Daniel Moore

  7. Deep learning-based pancreas volume assessment in individuals with type 1 diabetes

    Article • BMC Medical Imaging, January 2022, Springer Science + Business Media

    Daniel Moore

  8. Letter to the Editor From Gregory and Moore: “Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study”

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2021, Endocrine Society

    Daniel Moore

  9. GBS infection in pregnant and non-pregnant women with diabetes mellitus

    Article • American Journal of Reproductive Immunology, October 2021, Wiley

    Joel Omage, Daniel Moore

  10. Metabolic preconditioning in CD4+ T cells restores inducible immune tolerance in lupus-prone mice

    Article • JCI Insight, October 2021, American Society for Clinical Investigation

    Daniel Moore

  11. Development of a standardized MRI protocol for pancreas assessment in humans

    Article • PLOS One, August 2021, PLOS

    Daniel Moore

  12. High-Throughput Detection of Autoantigen-Specific B Cells Among Distinct Functional Subsets in Autoimmune Donors

    Article • Frontiers in Immunology, May 2021, Frontiers

    Daniel Moore

  13. Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526–532

    Article • Diabetes Care, May 2021, American Diabetes Association

    Justin Gregory, Daniel Moore

  14. The Dual Burden of Type 1 Diabetes and COVID-19

    Article • Annals of Internal Medicine, May 2021, American College of Physicians

    Daniel Moore

  15. The Rapid Transition to Telemedicine and Its Effect on Access to Care for Patients With Type 1 Diabetes During the COVID-19 Pandemic

    Article • Diabetes Care, April 2021, American Diabetes Association

    Daniel Tilden, Daniel Moore

  16. Perspectives from the Society for Pediatric Research: advice on sustaining science and mentoring during COVID-19

    Article • Pediatric Research, January 2021, Springer Science + Business Media

    Daniel Moore

  17. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes

    Article • Diabetes Care, December 2020, American Diabetes Association

    Justin Gregory, Daniel Moore

  18. The Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 Diabetes

    Article • Diabetes, April 2020, American Diabetes Association

    Daniel Moore

  19. A Special Thanks to the Reviewers of Diabetes

    Article • Diabetes, April 2020, American Diabetes Association

    Daniel Moore, Gaetano Santulli

  20. Fixing the leaky pipeline: identifying solutions for improving pediatrician-scientist training during pediatric residency

    Article • Pediatric Research, March 2020, Springer Science + Business Media

    Daniel Moore

  21. Repeatability and Reproducibility of Pancreas Volume Measurements Using MRI

    Article • Scientific Reports, March 2020, Springer Science + Business Media

    Daniel Moore

  22. Correlating maternal iodine status with neonatal thyroid function in two hospital populations in Ghana: a multicenter cross-sectional pilot study

    Article • BMC Pediatrics, January 2020, Springer Science + Business Media

    Daniel Moore

  23. Regulation of Diabetogenic Immunity by IL-15–Activated Regulatory CD8 T Cells in Type 1 Diabetes

    Article • The Journal of Immunology, July 2019, The American Association of Immunologists

    Daniel Moore

  24. 185-LB: Repeatability and Reproducibility of Pancreas Volume Measurements Using MRI

    Article • Diabetes, June 2019, American Diabetes Association

    Daniel Moore

  25. Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison to GCK-MODY (MODY2)

    Article • Diabetes, May 2019, American Diabetes Association

    Justin Gregory, Daniel Moore, Siri Atma W Greeley

  26. B lymphocytes protect islet β cells in diabetes-prone NOD mice treated with imatinib

    Article • JCI Insight, May 2019, American Society for Clinical Investigation

    Daniel Moore

  27. Pancreas Volume Declines During the First Year After Diagnosis of Type 1 Diabetes and Exhibits Altered Diffusion at Disease Onset

    Article • Diabetes Care, December 2018, American Diabetes Association

    Daniel Moore

  28. Distinct mucosal microbial communities in infants with surgical necrotizing enterocolitis correlate with age and antibiotic exposure

    Article • PLOS One, October 2018, PLOS

    Daniel Moore

  29. Cutting Edge: IL-1α and Not IL-1β Drives IL-1R1–Dependent Neonatal Murine Sepsis Lethality

    Article • The Journal of Immunology, October 2018, The American Association of Immunologists

    Daniel Moore

  30. Evidence for the Role of the Cecal Microbiome in Maintenance of Immune Regulation and Homeostasis

    Article • Annals of Surgery, September 2018, Wolters Kluwer Health

    Daniel Moore

  31. Supplementation of p40, a Lactobacillus rhamnosus GG-derived protein, in early life promotes epidermal growth factor receptor-dependent intestinal development and long-term health outcomes

    Article • Mucosal Immunology, September 2018, Elsevier

    Daniel Moore

  32. Healthy Donor Polyclonal IgMs Diminish B-Lymphocyte Autoreactivity, Enhance Regulatory T-Cell Generation, and Reverse Type 1 Diabetes in NOD Mice

    Article • Diabetes, August 2018, American Diabetes Association

    Daniel Moore

  33. Identification of a gene-expression predictor for diagnosis and personalized stratification of lupus patients

    Article • PLOS One, July 2018, PLOS

    Daniel Moore

  34. Limited achievement of NIH research independence by pediatric K award recipients

    Article • Pediatric Research, June 2018, Springer Science + Business Media

    Daniel Moore

  35. Bacterial DNA is present in the fetal intestine and overlaps with that in the placenta in mice

    Article • PLOS One, May 2018, PLOS

    Daniel Moore

  36. Pancreas Volume Declines over the First Year after Diagnosis with Type 1 Diabetes (T1D)

    Article • Diabetes, May 2018, American Diabetes Association

    Daniel Moore

  37. In Utero Exposure to Histological Chorioamnionitis Primes the Exometabolomic Profiles of Preterm CD4+ T Lymphocytes

    Article • The Journal of Immunology, September 2017, The American Association of Immunologists

    Daniel Moore

  38. Timing of Meal Insulin and Its Relation to Adherence to Therapy in Type 1 Diabetes

    Article • Journal of Diabetes Science and Technology, September 2017, SAGE Publications

    Daniel Moore

  39. Host Expression of the CD8 Treg/NK Cell Restriction Element Qa-1 is Dispensable for Transplant Tolerance

    Article • Scientific Reports, September 2017, Springer Science + Business Media

    Daniel Moore

  40. Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition

    Article • Oncogene, April 2017, Springer Science + Business Media

    Daniel Moore

  41. ERAD-icating mutant insulin promotes functional insulin secretion

    Article • Science Translational Medicine, January 2017, American Association for the Advancement of Science

    Daniel Moore

  42. An overview of the necessary thymic contributions to tolerance in transplantation

    Article • Clinical Immunology, December 2016, Elsevier

    Daniel Moore

  43. Grave effects of a specific immune therapy

    Article • Science Translational Medicine, November 2016, American Association for the Advancement of Science

    Daniel Moore

  44. Hematopoietic Stem Cell Mobilization Is Necessary but Not Sufficient for Tolerance in Islet Transplantation

    Article • Diabetes, October 2016, American Diabetes Association

    Daniel Moore

  45. The inflammasome keeps on breaking your heart

    Article • Science Translational Medicine, October 2016, American Association for the Advancement of Science

    Daniel Moore

  46. New onset diabetes mellitus after heart transplantation in children is a common but potentially modifiable burden

    Article • Pediatric Transplantation, October 2016, Wiley

    Daniel Moore

  47. Sympathy for low blood sugar is felt in your gut

    Article • Science Translational Medicine, September 2016, American Association for the Advancement of Science

    Daniel Moore

  48. Viral infection crosses up antigen presentation to drive autoimmunity

    Article • Science Translational Medicine, July 2016, American Association for the Advancement of Science

    Daniel Moore

  49. Use of the Electronic Medical Record to Assess Pancreas Size in Type 1 Diabetes

    Article • PLOS One, July 2016, PLOS

    Daniel Moore

  50. Activation of Human T Cells in Hypertension

    Article • Hypertension, July 2016, Wolters Kluwer Health

    Daniel Moore

  51. An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells

    Article • Mucosal Immunology, June 2016, Springer Science + Business Media

    Daniel Moore

  52. Who knows best—your mother or her microbiome?

    Article • Science Translational Medicine, June 2016, American Association for the Advancement of Science

    Daniel Moore

  53. Sex (steroids) is in the AIRE

    Article • Science Translational Medicine, May 2016, American Association for the Advancement of Science

    Daniel Moore

  54. Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18

    Article • Proceedings of the National Academy of Sciences, April 2016, Proceedings of the National Academy of Sciences

    Daniel Moore

  55. Neonatal colonization of mice with LGG promotes intestinal development and decreases susceptibility to colitis in adulthood

    Article • Mucosal Immunology, April 2016, Springer Science + Business Media

    Daniel Moore

  56. Limited diversity sparks inflammation at the mucosal border

    Article • Science Translational Medicine, March 2016, American Association for the Advancement of Science

    Daniel Moore

  57. Lupus‐Prone Mice Resist Immune Regulation and Transplant Tolerance Induction

    Article • Arabian archaeology and epigraphy, September 2015, Wiley

    Daniel Moore

  58. Neonatal CD71+ Erythroid Cells Do Not Modify Murine Sepsis Mortality

    Article • The Journal of Immunology, June 2015, The American Association of Immunologists

    Daniel Moore

  59. A Review of Adolescent Adherence in Type 1 Diabetes and the Untapped Potential of Diabetes Providers to Improve Outcomes

    Article • Current Diabetes Reports, June 2015, Springer Science + Business Media

    Daniel Moore

  60. Regulation of B lymphocyte responses to Toll-like receptor ligand binding during diabetes prevention in non-obese diabetic (NOD) mice

    Article • Journal of Diabetes, March 2015, Wiley

    Daniel Moore

  61. The “Genomic Storm” Induced by Bacterial Endotoxin Is Calmed by a Nuclear Transport Modifier That Attenuates Localized and Systemic Inflammation

    Article • PLOS One, October 2014, PLOS

    Daniel Moore

  62. Dysregulation of T Lymphocyte Proliferative Responses in Autoimmunity

    Article • PLOS One, August 2014, PLOS

    Daniel Moore

  63. An immunosufficient murine model for the study of human islets

    Article • Xenotransplantation, July 2014, Wiley

    Daniel Moore

  64. Small Intestinal Intraepithelial TCRγδ+ T Lymphocytes Are Present in the Premature Intestine but Selectively Reduced in Surgical Necrotizing Enterocolitis

    Article • PLOS One, June 2014, PLOS

    Dr Michael J Rosen, Daniel Moore

  65. Early life establishment of site-specific microbial communities in the gut

    Article • Gut Microbes, March 2014, Taylor & Francis

    Dr Yi-Wei Tang, Daniel Moore

  66. Clinical predictors of autoimmune and severe atopic disease in pediatric heart transplant recipients

    Article • Pediatric Transplantation, December 2013, Wiley

    Daniel Moore

  67. The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients

    Article • Diabetes Care, July 2013, American Diabetes Association

    Daniel Moore

  68. The Effects of Inpatient Hybrid Closed-Loop Therapy Initiated Within 1 Week of Type 1 Diabetes DiagnosisDiabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups

    Article • Diabetes Technology & Therapeutics, May 2013, Mary Ann Liebert Inc

    Daniel Moore

  69. Type 1 Diabetes Mellitus

    Article • Pediatrics in Review, May 2013, American Academy of Pediatrics (AAP)

    Daniel Moore

  70. Mechanisms of regulatory T cell counter-regulation by innate immunity

    Article • Transplantation Reviews, April 2013, Elsevier

    Daniel Moore

  71. Nuclear Transport Modulation Reduces Hypercholesterolemia, Atherosclerosis, and Fatty Liver

    Article • Journal of the American Heart Association, March 2013, Wolters Kluwer Health

    Daniel Moore

  72. Bioluminescence Imaging Reveals Dynamics of Beta Cell Loss in the Non-Obese Diabetic (NOD) Mouse Model

    Article • PLOS One, March 2013, PLOS

    Adrienne N Dula, Daniel Moore

  73. Factors That Influence Parental Attitudes toward Enrollment in Type 1 Diabetes Trials

    Article • PLOS One, August 2012, PLOS

    Daniel Moore

  74. Clinical assessment of HNF1A and GCK variants and identification of a novel mutation causing MODY2

    Article • Diabetes Research and Clinical Practice, May 2012, Elsevier

    Daniel Moore

  75. Regulatory properties of the intestinal microbiome effecting the development and treatment of diabetes

    Article • Current Opinion in Endocrinology Diabetes and Obesity, April 2012, Wolters Kluwer Health

    Daniel Moore

  76. Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies

    Article • Diabetes Care, March 2012, American Diabetes Association

    Daniel Moore

  77. Cutting Edge: The “Death” Adaptor CRADD/RAIDD Targets BCL10 and Suppresses Agonist-Induced Cytokine Expression in T Lymphocytes

    Article • The Journal of Immunology, February 2012, The American Association of Immunologists

    Daniel Moore

  78. Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios

    Article • Gut, January 2012, BMJ

    Dr Michael J Rosen, Daniel Moore

  79. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity

    Article • Blood, January 2012, American Society of Hematology

    Dr James E Crowe, Daniel Moore

  80. A Correction to the Research Article Titled: "Inhibition of Transplantation Tolerance by Immune Senescence Is Reversed by Endocrine Modulation" by G. Zhao, D. J. Moore, J. I. Kim, K. M. Lee, M. R. O'Connor, P. E. Duff, M. Yang, J. Lei, J. F. Markmann, ...

    Article • Science Translational Medicine, December 2011, American Association for the Advancement of Science

    Daniel Moore

  81. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

    Article • The Lancet, July 2011, Elsevier

    Daniel Moore

  82. Autoimmune Alternating Hypo- and Hyperthyroidism in Children

    Article • Clinical Pediatrics, June 2011, SAGE Publications

    Daniel Moore

  83. Inhibition of Transplantation Tolerance by Immune Senescence Is Reversed by Endocrine Modulation

    Article • Science Translational Medicine, June 2011, American Association for the Advancement of Science

    Daniel Moore

  84. Can technological solutions for diabetes replace islet cell function?

    Article • Organogenesis, January 2011, Taylor & Francis

    Daniel Moore

  85. In Vivo Islet Protection by a Nuclear Import Inhibitor in a Mouse Model of Type 1 Diabetes

    Article • PLOS One, October 2010, PLOS

    Daniel Moore

  86. An Unexpected Counter-Regulatory Role of IL-10 in B-Lymphocyte-Mediated Transplantation Tolerance

    Article • Arabian archaeology and epigraphy, April 2010, Wiley

    Daniel Moore

  87. Incorporating Type 1 Diabetes Prevention Into Clinical Practice

    Article • Clinical Diabetes, March 2010, American Diabetes Association

    Daniel Moore

  88. Blockade of GITR-GITRL interaction maintains Treg function to prolong allograft survival

    Article • European Journal of Immunology, February 2010, Wiley

    Daniel Moore

  89. Accounting for chance in the calculus of autoimmune disease

    Article • Medical Hypotheses, February 2010, Elsevier

    Daniel Moore

  90. Regulatory T-Cell Counter-Regulation by Innate Immunity Is a Barrier to Transplantation Tolerance

    Article • Arabian archaeology and epigraphy, December 2009, Wiley

    Daniel Moore

  91. GITR Blockade Facilitates Treg Mediated Allograft Survival

    Article • Transplantation, November 2009, Wolters Kluwer Health

    Daniel Moore

  92. Reduced Diabetes in btk-Deficient Nonobese Diabetic Mice and Restoration of Diabetes with Provision of an Anti-Insulin IgH Chain Transgene

    Article • The Journal of Immunology, October 2009, The American Association of Immunologists

    Daniel Moore

  93. Resolving the Conundrum of Islet Transplantation by Linking Metabolic Dysregulation, Inflammation, and Immune Regulation

    Article • Endocrine Reviews, August 2008, Endocrine Society

    Daniel Moore

  94. A direct comparison of rejection by CD8 and CD4 T cells in a transgenic model of allotransplantation

    Article • Archivum Immunologiae et Therapiae Experimentalis, May 2008, Springer Science + Business Media

    Daniel Moore

  95. Inhibition of ICAM-1/LFA-1 Interactions Prevents B-Cell-Dependent Anti-CD45RB-Induced Transplantation Tolerance

    Article • Transplantation, March 2008, Wolters Kluwer Health

    Daniel Moore

  96. Progress Toward Antibody-Induced Transplantation Tolerance

    Article • Critical Reviews™ in Immunology, January 2007, Begell House

    Daniel Moore

  97. Avenues for immunomodulation and graft protection by gene therapy in transplantation

    Article • Transplant International, June 2006, Wiley

    Daniel Moore

  98. T-reg Mediated Suppression of the Allograft Response in the Draining Lymph Node

    Article • Transplantation, April 2006, Wolters Kluwer Health

    Dr Muhammad Mansoor Mohiuddin, Daniel Moore

  99. Posttransplantation Lymphoproliferative Disorder in Pediatric Recipients of Solid Organ Transplants: Timing and Location of Disease

    Article • American Journal of Roentgenology, November 2005, American Roentgen Ray Society

    Daniel Moore

  100. T-regs inhibit effector T cell accumulation to prolong allograft survival

    Article • Journal of the American College of Surgeons, September 2005, Elsevier

    Daniel Moore

  101. NOD B-cells Are Insufficient to Incite T-Cell-Mediated Anti-islet Autoimmunity

    Article • Diabetes, June 2005, American Diabetes Association

    Daniel Moore, Siri Atma W Greeley

  102. Inhibition of ICAM-1/LFA-1 interaction prevents allograft tolerance induced by anti-CD45RB

    Article • Journal of the American College of Surgeons, September 2004, Elsevier

    Daniel Moore

  103. Resistance to anti-CD45RB-induced tolerance in NOD mice: mechanisms involved

    Article • Transplant International, June 2004, Wiley

    Daniel Moore

  104. Promotion of Allograft Survival by CD4+CD25+ Regulatory T Cells: Evidence for In Vivo Inhibition of Effector Cell Proliferation

    Article • The Journal of Immunology, May 2004, The American Association of Immunologists

    Daniel Moore

  105. Resistance to anti-CD45RB-induced tolerance in NOD mice: mechanisms involved

    Article • Transplant International, May 2004, Wiley

    Daniel Moore

  106. Specialized CC-chemokine secretion by Th1 cells in destructive autoimmune myocarditis

    Article • Journal of Autoimmunity, December 2003, Elsevier

    Daniel Moore, Siri Atma W Greeley

  107. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice1

    Article • Transplantation, April 2003, Wolters Kluwer Health

    Daniel Moore

  108. CD25+ Immunoregulatory CD4 T Cells Mediate Acquired Central Transplantation Tolerance

    Article • The Journal of Immunology, January 2003, The American Association of Immunologists

    Daniel Moore

  109. Transgenic T cells persist in an adoptive transfer model of mouse liver transplantation tolerance

    Article • Transplantation Proceedings, December 2002, Elsevier

    Daniel Moore

  110. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice

    Article • Nature Reports Stem Cells, April 2002, Springer Science + Business Media

    Daniel Moore, Siri Atma W Greeley

  111. Activation and Association of the Tec Tyrosine Kinase with the Human Prolactin Receptor: Mapping of a Tec/Vav1-Receptor Binding Site

    Article • Molecular Endocrinology, May 2001, Endocrine Society

    Daniel Moore

  112. Contribution of the Innate Immune System to Autoimmune Diabetes: A Role for the CR1/CR2 Complement Receptors

    Article • Cellular Immunology, December 1999, Elsevier

    Daniel Moore

  113. MHC Class II alpha/beta Heterodimeric Cell Surface Molecules Expressed from a Single Proviral Genome

    Article • Human Gene Therapy, September 1999, Mary Ann Liebert Inc

    Daniel Moore

  114. Contribution of the Innate Immune System to Autoimmune Diabetes: A Role for the CR1/CR2 Complement Receptors

    Article • Cellular Immunology, July 1999, Elsevier

    Daniel Moore